IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 1 filers reported holding IVERIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $51,750,956 | +14.3% | 2,127,043 | +0.6% | 5.36% | -17.5% |
| Q4 2022 | $45,276,326 | +0.8% | 2,114,728 | -15.5% | 6.50% | +6.5% |
| Q3 2022 | $44,897,000 | +410.4% | 2,502,601 | +173.7% | 6.10% | +344.6% |
| Q2 2022 | $8,796,000 | -45.8% | 914,346 | -5.2% | 1.37% | -34.5% |
| Q1 2022 | $16,232,000 | -9.1% | 964,476 | -9.7% | 2.09% | +17.1% |
| Q4 2021 | $17,863,000 | +0.6% | 1,068,376 | -2.3% | 1.79% | -35.4% |
| Q3 2021 | $17,751,000 | +0.2% | 1,093,020 | -61.1% | 2.77% | +1.5% |
| Q2 2021 | $17,721,000 | -15.2% | 2,808,343 | -16.9% | 2.72% | -27.6% |
| Q1 2021 | $20,894,000 | +89.3% | 3,380,979 | +111.7% | 3.76% | +158.6% |
| Q4 2020 | $11,037,000 | +16.1% | 1,597,279 | -5.3% | 1.46% | -71.1% |
| Q3 2020 | $9,508,000 | +14.6% | 1,685,879 | +3.6% | 5.04% | +6.6% |
| Q2 2020 | $8,296,000 | +50.0% | 1,626,701 | +1.2% | 4.73% | -26.5% |
| Q1 2020 | $5,529,000 | -3.6% | 1,607,153 | +140.5% | 6.43% | +16.3% |
| Q4 2019 | $5,734,000 | – | 668,371 | – | 5.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |